Concepedia

Maureen McKenna

MM

4

Publications

162

Citations

4

H-Index

2011

Active since

Affiliations

Novartis (United States)(Current)

Maureen McKenna is an author at Novartis (United States) specializing in drug discovery, medicine, and medicinal chemistry.

Top concepts

MedicineDrug DiscoveryCell BiologyPharmacologyPharmacotherapyNatural SciencesMolecular BiologyStructural BiologyMedicinal ChemistryOncology

Publications per year

2011–2016

4

Publications

4

Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase

Andreas Lingel, Martin Sendzik, Ying Huang et al. · Journal of Medicinal Chemistry · 2016 · 56 citations · Full text

Histone Modifications, Eed Binders Allosterically, Epigenetic Change +21

Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma

Teresa E. Williams, Sharadha Subramanian, Joelle Verhagen et al. · ACS Medicinal Chemistry Letters · 2015 · 53 citations · Full text

Medicinal Chemistry, Drug Target, Oncology +15

Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990

Christopher M. McBride, Barry H. Levine, Yi Xia et al. · Journal of Medicinal Chemistry · 2014 · 27 citations · Full text

Structure–activity Relationship, Pharmaceutical Science, Commercial Hit +16

3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors

Mika Lindvall, Christopher M. McBride, Maureen McKenna et al. · ACS Medicinal Chemistry Letters · 2011 · 26 citations · Full text

Rows per page

1–4 of 4